Efficacy and safety of interferon alfa-2b and ribavirin combination therapy in chronic hepatitis C patients: A Czech multicenter study

被引：0
|
作者：
Husa, P
Krtek, V
Svejda, J
Stransky, J
Cieslarova, B
Nadvornik, V
Ehrmann, J
Urbanek, P
Volfova, M
机构：
[1] Teaching Hosp, Brno, Czech Republic
[2] Teaching Hosp, Krc, Czech Republic
[3] Private Doctors Assoc, Usti Nad Labem, Czech Republic
[4] Teaching Hosp Kralovske Vinohadry, Prague, Czech Republic
[5] Mil Hosp, Prague, Czech Republic
[6] Teaching Hosp, Olomouc, Czech Republic
[7] Teaching Hosp Praha 2, Prague, Czech Republic
[8] Teaching Hosp, Hradec Kralove, Czech Republic
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80849-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
848
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [1] Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C
    Nagayama, A
    Tanaka, A
    Ankoh, H
    Narita, T
    Izumi, M
    Miyake, K
    Takikawa, H
    HEPATOLOGY RESEARCH, 2005, 32 (02) : 101 - 106
  • [2] Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children:: Efficacy, safety, and pharmacokinetics
    González-Peralta, RP
    Kelly, DA
    Haber, B
    Molleston, J
    Murray, KF
    Jonas, MM
    Shelton, M
    Mieli-Vergani, G
    Lurie, Y
    Martin, S
    Lang, T
    Baczkowski, A
    Geffner, M
    Gupta, S
    Laughlin, M
    HEPATOLOGY, 2005, 42 (05) : 1010 - 1018
  • [3] Safety and efficacy of interferon alfa-2b and ribavirin combination therapy for the treatment of hepatitis C in patients coinfected with HIV.
    Bini, EJ
    Reid, M
    Mannix, RA
    Wu, B
    HEPATOLOGY, 2001, 34 (04) : 335A - 335A
  • [4] Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C - Relapsed and treatment-naive patients
    Maddrey, WC
    SEMINARS IN LIVER DISEASE, 1999, 19 : 67 - 75
  • [5] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [6] Safety, efficacy and pharmacokinetics of interferon alfa-2B and ribavirin in children with chronic hepatitis C.
    Bunn, S
    Kelly, D
    Murray, KF
    Shelton, M
    Olson, A
    Mieli-Vergani, G
    Zambas, D
    Gupta, SK
    Glue, P
    HEPATOLOGY, 2000, 32 (04) : 350A - 350A
  • [7] Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C
    Yeh, Frank
    Gordon, Fredric D.
    FUTURE VIROLOGY, 2007, 2 (06) : 553 - 563
  • [8] Effectiveness of interferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting
    Kumar, D
    Wallington-Beddoe, C
    George, J
    Lin, R
    Samarasinghe, D
    Liddle, C
    Farrell, GC
    MEDICAL JOURNAL OF AUSTRALIA, 2003, 178 (06) : 267 - 271
  • [9] Combination therapy with pegylated interferon ALFA-2B and ribavirin for patients with chronic hepatitis C and normal aminotransferase levels
    Kotano, Yoshiaki
    Ishigami, Mosatoshi
    Nakano, Isao
    Hayashi, Kozuhiko
    Honda, Takashi
    Goto, Hidemi
    HEPATOLOGY, 2007, 46 (04) : 397A - 397A
  • [10] Safety, efficacy, and pharmacokinetics of interferon alfa-2b plus ribavirin in children with chronic hepatitis C.
    Kelly, DA
    Bunn, SK
    Apelian, D
    Baczkowski, A
    Gupta, S
    Laughlin, M
    Cohard, M
    HEPATOLOGY, 2001, 34 (04) : 342A - 342A
12345